Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in FH cause hereditary leiomyomatosis and renal cell cancer (HLRCC) (7).”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [7]
In the citing paper
“Familial cancer syndromes caused by fumarate hydratase (FH) or succinate dehydrogenase (SDH) deletion suggest that these TCA enzymes can behave as classical tumor suppressors.”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Tomlinson et al., 2002
In the citing paper
“Similarly, germline mutations in the broadly expressed enzyme fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma, a familial syndrome of uterine and cutaneous leiomyomas and kidney cancer, without susceptibility to more common tumors (11).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [11]
In the citing paper
“In 2001, mutation of fumarate hydratase leading to its inactivation was discovered in renal cell cancer129. Mutation of this enzyme leads to fumarate accumulation not only in skin cancer and uterine leiomyomas but also in breast, bladder, and Leydig cell tumors130.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [130]
In the citing paper
“Consistently, heterozygous germline mutations in genes encoding the TCA cycle enzymes involved in the breakdown of these metabolites—SDH and FH—have been shown to facilitate the pathogenesis of certain rare cancers (e.g., paragangliomas) and inherited cancer-predisposition syndromes (181, 182, 183).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [183]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Inherited susceptibility to uterine leiomyomas and renal cell cancer
Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., & Aaltonen, L. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633798 · Cited by 669
Fumarase C, the stable fumarase of Escherichia coli, is controlled by the soxRS regulon.
Liochev, S. I., & Fridovich, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5892 · Cited by 239
The VHL tumour-suppressor gene paradigm
Kaelin, W. G., & Maher, E. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01558-3 · Cited by 213 · cited 1×
“, individuals with von Hippel–Lindau syndrome are predisposed to both phaeochromocytomas and renal carcinoma”
BackgroundKiuru, M., Launonen, V., Hietala, M., Aittomäki, K., Vierimaa, O., Salovaara, R., Arola, J., Pukkala, E., Sistonen, P., Herva, R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61757-9 · Cited by 209
Bourgeron, T., Chretien, D., Poggi-Bach, J., Doonan, S., Rabier, D., Letouzé, P., Munnich, A., Rötig, A., Landrieu, P., & Rustin, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117261 · Cited by 160
Alam, N. A., Bevan, S., Churchman, M., Barclay, E., Barker, K., Jaeger, E. E. M., Nelson, H. M., Healy, E., Pembroke, A. C., Friedmann, P. S., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/320124 · Cited by 160
Familial predisposition to uterine leiomyomas
Vikhliaeva, E. M., Сагдуллаевна, Х. З., & Nd, F. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02533-i · Cited by 152 · cited 1×
“gif" NDATA ITEM> ]> Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesi”
Background
Cited by
Items 601–700 of 1,000
Imaging of hereditary renal cancer
Choyke, P. L. (2003) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(03)00068-x · Cited by 37
“Although the cutaneous leiomyomas do not degenerate into malignancies in general, a few cases of cutaneous leiomyosarcomas have been reported [45].”
BackgroundInfluentialThe TGF-β/HDAC7 axis suppresses TCA cycle metabolism in renal cancer
Nam, H., Kundu, A., Karki, S., Brinkley, G. J., Chandrashekar, D. S., Kirkman, R. L., Liu, J., Liberti, M. V., Locasale, J. W., Mitchell, T., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148438 · Cited by 36
Renal cell carcinoma: Evolving and emerging subtypes
Crumley, S. M., Divatia, M. K., Truong, L. D., Shen, S. S., Ayala, A. G., & Ro, J. Y. (2013) · World Journal of Clinical Cases · doi:10.12998/wjcc.v1.i9.262 · Cited by 36
Phosphoglycerate Dehydrogenase: Potential Therapeutic Target and Putative Metabolic Oncogene
Zogg, C. K. (2014) · Journal of Oncology · doi:10.1155/2014/524101 · Cited by 39
Familial and Hereditary Renal Cancer Syndromes
Coleman, J. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.014 · Cited by 42
Metabolic signatures differentiate ovarian from colon cancer cell lines
Halama, A., Guerrouahen, B. S., Pasquier, J., Diboun, I., Karoly, E. D., Suhre, K., & Rafii, A. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0576-z · Cited by 41
“Notably, alterations in the activity of TCA cycle enzymes, particularly succinate dehydrogenase (SDH) and fumarate hydratase (FH), have been implicated in tumor susceptibility to chemotherapy [34, 35].”
Liu, C., Dillon, J. L., Beavis, A., Liu, Y., Lombardo, K. A., Fader, A. N., Hung, C., Wu, T.-C., VANG, R. S., García, J. E., et al. (2019) · Histopathology · doi:10.1111/his.14007 · Cited by 36
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
Nikolovski, I., Carlo, M. I., Chen, Y., & Vargas, H. A. (2021) · Cancer Imaging · doi:10.1186/s40644-021-00392-9 · Cited by 36
“HLRCC is caused by heterozygous germline mutations in the FH gene located on chromosome 1, which encodes FH, a critical component of the Krebs cycle [2, 3].”
BackgroundCharacteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
Sepe, P., Ottini, A., Pircher, C. C., Franza, A., Claps, M., Guadalupi, V., Verzoni, E., & Procopio, G. (2021) · Cancers · doi:10.3390/cancers13153807 · Cited by 38
“HIF-1 is a transcription factor involved in homeostasis, vascularization, anaerobic metabolism, and immunological responses [40].”
BackgroundInfluentialSchaefer, I., Hornick, J. L., & Bovée, J. V. M. G. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0003-6 · Cited by 38
“Finally, inactivating germline mutations of FH are associated with the hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome, which includes benign cutaneous and uterine leiomyomas and renal cell carcinoma [9].”
VEGF inhibitors in renal cell carcinoma.
Vachhani, P. J., & George, S. (2016) · PubMed · Cited by 36
Garg, K., Karnezis, A. N., & Rabban, J. T. (2018) · Pathology · doi:10.1016/j.pathol.2017.10.009 · Cited by 37
Yehia, L., Ni, Y., Fěng, F., Seyfi, M., Sadler, T. M., Frazier, T. W., & Eng, C. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.09.004 · Cited by 36
Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer
Kang, J.-S., Nam, L. B., Yoo, O.-K., & Keum, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114002 · Cited by 37
Iribe, Y., Furuya, M., Shibata, Y., Yasui, M., Funahashi, M., Ota, J., Iwashita, H., Nagashima, Y., Hasumi, H., Hayashi, N., et al. (2020) · Familial Cancer · doi:10.1007/s10689-020-00195-0 · Cited by 38
Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
Zhao, Y., Feng, F., Guo, Q., Wang, Y., & Zhao, R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i34.5074 · Cited by 52
Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
Clerici, S., & Boletta, A. (2020) · Cancers · doi:10.3390/cancers12113458 · Cited by 38
Hamza, A., Sirohi, D., Smith, S. C., & Amin, M. B. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000321 · Cited by 37
Ahvenainen, T., Tolvanen, J., Kämpjärvi, K., Uimari, O., Ahtikoski, A., Mäkinen, N., Heikinheimo, O., Aaltonen, L. A., Karhu, A., Bützow, R., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001826 · Cited by 36
Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis
Egan, G., & Schimmer, A. D. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.11.004 · Cited by 37
Genetics of Familial Renal Cancers
Maher, E. R. (2010) · Nephron Experimental Nephrology · doi:10.1159/000320892 · Cited by 40
“The renal tumours in HPRC are characterized as type 1 papillary and have a better prognosis than type 2 papillary RCC. HPRC is very rare (approximate incidence 1 per 10 million persons), but identification of germline MET mutations allows precise diagnosis and targeted surveillance of mutation carriers. Hereditary Lei…”
BackgroundGermline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma
Ylisaukko‐oja, S. K., Cybulski, C., Lehtonen, R., Kiuru, M. H., Trubicka, J., Szymañska, A., Szymańska-Pasternak, J., Dyrskjøt, L., Bützow, R. C., Orntoft, T. F., et al. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201630 · Cited by 35
Targeted therapies for non-clear renal cell carcinoma
Singer, E. A., Bratslavsky, G., Linehan, W. M., & Srinivasan, R. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0148-3 · Cited by 35
“FH functions as a classic tumor suppressor, with both copies inactivated in tumors [29].”
Choice of Operation for Clinically Localized Renal Tumor
Nguyen, C. T., Campbell, S. C., & Novick, A. C. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.002 · Cited by 35
Warburg and Krebs and related effects in cancer
Unterlass, J. E., & Curtin, N. J. (2019) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2019.4 · Cited by 37
Zbar, B., Glenn, G. M., Merino, M. J., Middelton, L. A., Peterson, J. C., Toro, J. R., Coleman, J., Pinto, P. A., Schmidt, L. S., Choyke, P. L., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.09.037 · Cited by 35
Tumor metabolism: new opportunities for cancer therapy
Mérida, I., & Ávila‐Flores, A. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0117-6 · Cited by 37
Editorial: Molecular Targeting of VHL Gene Pathway in Clear Cell Kidney Cancer
Linehan, W. M. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000077210.05543.ae · Cited by 36
Mitochondrial metabolism and cancer metastasis
Yu, D., Liu, C., & Guo, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.42 · Cited by 35
“Several mitochondrial metabolites favor the EMT (9,30), in particular, fumarate (31), succinate (32) and 2-hydroxyglutarate (2HG) (33), which are accumulated when mutation or deletion in fumarate hydratase (FH) (31,34-36), succinate dehydrogenase (SDH) (37-41), and isocitrate dehydrogenases (IDHs) (42-44) occur respec…”
BackgroundNalbantoğlu, S., & Karadağ, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114031 · Cited by 39
Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways
Meng, W., Palmer, J. D., Siedow, M. R., Haque, S. J., & Chakravarti, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042246 · Cited by 40
“Heterozygous germline mutations of the FH gene have been found to relate to inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer [48].”
BackgroundComparative bioenergetic assessment of transformed cells using a cell energy budget platform
Zhdanov, A. V., Favre, C., O′Flaherty, L., Adam, J., O’Connor, R., Pollard, P. J., & Papkovsky, D. B. (2011) · Integrative Biology · doi:10.1039/c1ib00050k · Cited by 39
Alsolami, S., El-Bahrawy, M. A., Kalloger, S. E., Aldaoud, N., Pathak, T. B., Cheung, C. T., Mulligan, A. M., Tomlinson, I. P. M., Pollard, P. J., Gilks, C. B., et al. (2014) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000091 · Cited by 34
“Cases correctly identified 11/28 (39) 8/28 (29) 14/28 (50) 15/28 (54) 10/28 (36) 14/28 (50) Hereditary cases identified 4/18 (22) 5/18 (28) 7/18 (39) 8/18 (44) 2/18 (11) 4/18 (22) Sporadic cases identified 7/10 (70) 3/10 (30) 7/10 (70) 7/10 (70) 8/10 (80) 10/10 (100) Overall % equivocal cases 8/28 (29) 16/28 (57) 2/28…”
Aberrant mitochondrial function in ageing and cancer
Whitehall, J. C., & Greaves, L. C. (2019) · Biogerontology · doi:10.1007/s10522-019-09853-y · Cited by 35
Dominant versus recessive: Molecular mechanisms in metabolic disease
Zschocke, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1016-5 · Cited by 33
Recent Advances in Metabolic Profiling and Imaging of Prostate Cancer
Thapar, R., & Titus, M. A. (2014) · Current Metabolomics · doi:10.2174/2213235x02666140301002510 · Cited by 36
Bardella, C., Olivero, M., Lorenzato, A., Geuna, M., Adam, J., O'Flaherty, L., Rustin, P., Tomlinson, I., Pollard, P. J., & Di Renzo, M. F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06160-11 · Cited by 33
“The high frequency of inactivation of the second allele and loss of enzymatic activity in tumor cells indicate that FH is a tumor suppressor gene (56).”
BackgroundSelf-citationFumarase is involved in DNA double-strand break resection through a functional interaction with Sae2
Leshets, M., Ramamurthy, D., Lisby, M., Lehming, N., & Pines, O. (2017) · Current Genetics · doi:10.1007/s00294-017-0786-4 · Cited by 33
Tseng, P., Chen, C., Hu, K.-H., Cheng, H.-C., Lin, Y.-H., Tsai, W., Cheng, T., Wu, W.-H., Yeh, C., Lin, C.-C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24855 · Cited by 35
Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
Cascón, A., Remacha, L., Calsina, B., & Robledo, M. (2019) · Cancers · doi:10.3390/cancers11050683 · Cited by 35
“Chr: chromosome; ¥: penetrance data was included for genes with prevalence >1%; TCA: tricarboxylic acid; PGL: paraganglioma; NA: not applicable; H&N: head and neck paraganglioma; TAP: thoracic-abdominal-pelvic paraganglioma; PCC: pheochromocytoma; S: single; M: multiple BC: Biochemical predominant secretion; NA: norad…”
BackgroundMacklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 35
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 37
GRIM-19 function in cancer development
Moreira, S., Correia, M., Soares, P., & Máximo, V. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.05.011 · Cited by 34
Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening
Tolvanen, J., Uimari, O., Ryynänen, M., Aaltonen, L. A., & Vahteristo, P. (2012) · Human Reproduction · doi:10.1093/humrep/des105 · Cited by 33
Isocitrate dehydrogenase 1/2 mutational analyses and 2‐hydroxyglutarate measurements in Wilms tumors
Rakheja, D., Mitui, M., Boriack, R. L., & DeBerardinis, R. J. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22697 · Cited by 33
Hereditary Renal Tumor Syndromes: Imaging Findings and Management Strategies
Northrup, B. E., Jokerst, C. E., Grubb, R. L., Menias, C. O., Khanna, G., & Siegel, C. L. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.12.9079 · Cited by 33
“These, however, rarely transform into leiomyosarcoma [55].”
Energy Balance, Polymorphisms in the mTOR Pathway, and Renal Cell Carcinoma Risk
Shu, X., Lin, J. M., Wood, C. G., Tannir, N. M., & Wu, X. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt005 · Cited by 33
Alaghehbandan, R., Stehlík, J., Trpkov, K., Magi‐Galluzzi, C., Condom, E., Pané, M., Berney, D. M., Sibony, M., Suster, S. M., Agaimy, A., et al. (2017) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2017.04.007 · Cited by 34
Metabolic regulation in HPV associated head and neck squamous cell carcinoma
Chandel, V., Raj, S., Kumar, P., Gupta, S., Dhasmana, A., Kesari, K. K., Ruokolainen, J., Mehra, P., Das, B. C., Kamal, M. A., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118236 · Cited by 34
Ahvenainen, T., Lehtonen, H. J., Lehtonen, R., Vahteristo, P., Aittomäki, K., Baynam, G. S., Dommering, C. J., Eng, C., Gruber, S. B., Grönberg, H., et al. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.01.010 · Cited by 33
Jaberi, E., Chitsazian, F., Ali Shahidi, G., Rohani, M., Sina, F., Safari, I., Malakouti Nejad, M., Houshmand, M., Klotzle, B., & Elahi, E. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.45 · Cited by 33
Metabolic modulation of cancer: a new frontier with great translational potential
Kinnaird, A. S., & Michelakis, E. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1250-2 · Cited by 33
“Mutations in fumarase have been identified in almost all cases of the tumor su s cep t i b i l i t y synd rome , he r ed i t a r y leiomyomatosis, and renal cell carcinoma [54].”
BackgroundOxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
Pandkar, M. R., Dhamdhere, S. G., & Shukla, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188553 · Cited by 36
Rapid determination of tricarboxylic acid cycle enzyme activities in biological samples
Gonçalves, S., Paupe, V., Dassa, E. P., Brière, J.-J., Favier, J., Gimenez‐Roqueplo, A., Bénit, P., & Rustin, P. (2010) · BMC Biochemistry · doi:10.1186/1471-2091-11-5 · Cited by 35
“So far there has been only a limited number of diseases which have been associated with primary isolated or multiple defect of the TCAC [7,19,20,26-28].”
BackgroundKoski, T. A., Lehtonen, H. J., Jee, K. J., Ninomiya, S., Joosse, S. A., Vahteristo, P., Kiuru, M. H., Karhu, A., Sammalkorpi, H., Vanharanta, S., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20663 · Cited by 38
“Recent evidence suggests that pseudohypoxia caused by accumulation of a TCAC intermediate fumarate in fumarase deficient cells is at least one contributing factor.”
BackgroundInfluentialChuang, G. S., Martı́nez-Mir, A., Engler, D. E., Gmyrek, R., Zlotogorski, A., & Christiano, A. M. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01977.x · Cited by 32
Maita, S., Yuasa, T., Tsuchiya, N., Mitobe, Y., Narita, S., Horikawa, Y., Hatake, K., Fukui, I., Kimura, S. H., Maekawa, T., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26034 · Cited by 32
“Mesenchymal-epithelial transition factor (MET) and fumarate hydratase (FH) are considered to be the genes responsible for Type 1 and Type 2 papillary RCC, respectively.(24,25) MET, which is a proto-oncogene, encodes a tyrosine kinase membrane receptor, and activation of MET can indirectly promote angiogenesis and tumo…”
BackgroundKuiper, R. P., Vreede, L., Venkatachalam, R., Ricketts, C., Kamping, E. J., Verwiel, E. T. P., Govaerts, L. C. P., Dêbiec‐Rychter, M., Lerut, E., van Erp, F., et al. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.07.001 · Cited by 34
Dorai, T., Sawczuk, I. S., Pastorek, J., Wiernik, P. H., & Dutcher, J. P. (2006) · Cancer Investigation · doi:10.1080/07357900601062321 · Cited by 36
Natural history of the Nihon (Bhd gene mutant) rat, a novel model for human Birt–Hogg–Dubé syndrome
Kouchi, M., Okimoto, K., Matsumoto, I., Tanaka, K., Yasuba, M., & Hino, O. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-0142-9 · Cited by 36
“The vast majority of RCCs are sporadic, but there are several hereditary syndromes associated with RCCs, including Von Hippel–Lindau disease, hereditary papillary renal carcinoma, hereditary leiomyomatosis and renal cell carcinoma (HLRCC), familial renal oncocytoma, tuberous sclerosis, and Birt–Hogg–Dubé (BHD) syndrom…”
BackgroundMoonlighting proteins: complications and implications for proteomics research
Jeffery, C. J. (2004) · Drug Discovery Today TARGETS · doi:10.1016/s1741-8372(04)02405-3 · Cited by 34
Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes
Gatalica, Z., Lilleberg, S. L., Monzon, F. A., Koul, M. S., Bridge, J. A., Knezetic, J. A., Legendre, B. L., Sharma, P., & McCue, P. A. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.02.026 · Cited by 31
Vocke, C. D., Ricketts, C. J., Merino, M. J., Srinivasan, R., Metwalli, A. R., Middelton, L. A., Peterson, J. C., Yang, Y., & Linehan, W. M. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22452 · Cited by 31
“Several studies have reported germline complete deletions of the FH gene,5,9,15–17 and a few have estimated the extents of these deletions and identified the additional genes that would be lost in conjunction with FH.9,16 Several reports have demonstrated that germline deletion of FH is associated with cutaneous and u…”
BackgroundInfluentialGarg, K., & Rabban, J. T. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22905 · Cited by 31
Zyla, R. E., & Hodgson, A. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207830 · Cited by 32
Koltsova, A. S., Efimova, O. A., & Pendina, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065752 · Cited by 33
“Frequently referred to as the HLRCC syndrome (Hereditary Leiomyomatosis and Renal Cell Carcinoma), Reed’s syndrome is caused by germline mutations in FH, the gene encoding fumarate hydratase, a tricarboxylic acid cycle enzyme [88,89].”
BackgroundLi, A. M., & Ye, J. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-120857 · Cited by 36
Inhibiting Autophagy: A Novel Approach for the Treatment of Renal Cell Carcinoma
Lotze, M. T., Maranchie, J. K., & Appleman, L. J. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e31829da0d6 · Cited by 31
“Familial RCC has also been linked to disruption in genes encoding fumaratehydratase and succinate dehydrogenase subunit B: components of the mitochondrial-based tricarboxylic acidcycle.(1,2) Renal cell carcinoma stands out among cancers as being especially insensitive to cytotoxic chemotherapeutic agents, yet suscepti…”
BackgroundTowards imaging metabolic pathways in tissues
Dekker, T. J. A., Jones, E. A., Corver, W. E., van Zeijl, R. J. M., Deelder, A. M., Tollenaar, R. A. �. �., Mesker, W. E., Morreau, H. M., & McDonnell, L. A. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8305-7 · Cited by 31
Current understanding of somatic stem cells in leiomyoma formation
Mas, A., Cervelló, I., Gil-Sanchís, C., & Simón, C. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.04.051 · Cited by 31
“At the genetic level, several mutations, such as germline mutations causing fumarate hydratase deficiency (44), have been associated with leiomyoma formation.”
BackgroundGlutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 35
Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy
Wang, L., Williamson, S. R., Wang, M., Davidson, D. D., Zhang, S., Baldridge, L. A., Du, X., & Liang Cheng, C. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-39 · Cited by 31
“Loss of activity of the Krebs cycle enzyme fumarase hydratase (FH) in some cases of papillary type II RCC may also result in HIF upregulation [46], potentially providing an avenue for utilization of similar treatments in patients with PRCC.”
BackgroundCorrado, M., Scorrano, L., & Campello, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8727 · Cited by 34
“Moreover, a connection between cancer and altered metabolism was clearly established when mutations in genes encoding for the two TCA cycle enzymes succinate dehydrogenase (SDH) [18] and fumarate hydratase (FH) [19] were identified in human tumours.”
BackgroundPost-translational regulation of metabolism in fumarate hydratase deficient cancer cells
Gonçalves, E., Sciacovelli, M., Costa, A. S. H., Tran, M. G. B., Johnson, T. I., Machado, D., Frezza, C., & Sáez-Rodríguez, J. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.11.011 · Cited by 32
Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei
Zhang, Q., Poropatich, K., Ubago, J. M., Xie, J., Xu, X., Frizzell, N., Kim, J. J., Kong, B., & Wei, J. (2017) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000447 · Cited by 32
“Fumarate hydratase (FH) mutations are most notably seen in hereditary leiomyomatosis and renal cell carcinoma syndrome, also known as Reed syndrome, and they can also be seen with uterine leiomyomatosis (7).”
BackgroundThe epidemiology and pathogenesis of uterine fibroids
Munro, M. G., Tchaikovski, S. N., & Murji, A. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70527 · Cited by 39
“84,85 This condition is associated FIGURE 3 Schematic of the etiology, development, and molecular expressions of leiomyomas.”
Survival of the fittest: metabolic adaptations in cancer
Berardi, M. J., & Fantin, V. R. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.001 · Cited by 35
Population‐based survey of cancer risks in chromosome 3 translocation carriers
Woodward, E. R., Skytte, A., Crüger, D. G., & Maher, E. R. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20718 · Cited by 30
“…and, in addition to germline mutations in a variety of genes (e.g., VHL, MET, FLCN, SDHB, and FH genes) (Latif et al., 1993; Schmidt et al., 1997; Nickerson et al., 2002; Tomlinson et al., 2002; Ricketts et al., 2008), inherited RCC may be associated with constitutional chromosome 3 translocations.”
BackgroundPark, H., Ohshima, K., Nojima, S., Tahara, S., Kurashige, M., Hori, Y., Okuzaki, D., Wada, N., Ikeda, J., & Morii, E. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0017-0 · Cited by 32
Drusian, L., Nigro, E. A., Mannella, V., Pagliarini, R., Pema, M., Costa, A. S. H., Benigni, F., Larcher, A., Chiaravalli, M., Gaude, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.106 · Cited by 35
Pheochromocytoma: Gasping for Air
Jochmanová, I., Zhuang, Z., & Pacák, K. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0231-4 · Cited by 30
Differential metabolic consequences of fumarate hydratase and respiratory chain defects
Raimundo, N., Ahtinen, J., Fumić, K., Barić, I., Remes, A. M., Renkonen, R., Lapatto, R., & Suomalainen, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.008 · Cited by 32
Risk Factors, Classification, and Staging of Renal Cell Cancer
Laber, D. A. (2006) · Medical Oncology · doi:10.1385/mo:23:4:443 · Cited by 30
Testa, U., Pelosi, E., & Castelli, G. (2020) · Medicines · doi:10.3390/medicines7080044 · Cited by 33
Shen-Ong, G. L. C., Feng, Y., & Troyer, D. A. (2003) · PubMed · Cited by 30
Fumarate drives EMT in renal cancer
Sciacovelli, M., & Frezza, C. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.137 · Cited by 33
Wilms Tumor in a Child with L-2-hydroxyglutaric Aciduria
Rogers, R. E., DeBerardinis, R. J., Klesse, L. J., Boriack, R. L., Margraf, L. R., & Rakheja, D. (2010) · Pediatric and Developmental Pathology · doi:10.2350/09-12-0768-cr.1 · Cited by 29
“Fumarate hydratase (FH) mutations are responsible for a familial syndrome of uterine fibroids, skin leiomyomata, and renal papillary cell cancer [23].”
BackgroundFredericks, W. J., Yin, H., Lal, P., Raghunath, P. N., Malkowicz, S. B., Fredericks, N., Tomaszewski, J., Rauscher, F. J., & Malkowicz, S. B. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1985 · Cited by 30
Precision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management
Gomella, P. T., Linehan, W. M., & Ball, M. W. (2021) · Genes · doi:10.3390/genes12020261 · Cited by 32
Shen, T., Wang, H., Tang, B., Zhu, G., & Wang, X. (2023) · RNA Biology · doi:10.1080/15476286.2023.2216562 · Cited by 31
Critical roles and clinical perspectives of RNA methylation in cancer
Li, G., Yao, Q., Liu, P., Zhang, H., Liu, Y., Li, S., Shi, Y., Li, Z., & Zhu, W. (2024) · MedComm · doi:10.1002/mco2.559 · Cited by 34
No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome
Vahteristo, P., Koski, T. A., Näätsaari, L., Kiuru, M. H., Karhu, A., Herva, R., Sallinen, S., Kuismin, O., Björck, E., Richard, S., et al. (2009) · Familial Cancer · doi:10.1007/s10689-009-9312-2 · Cited by 34
“These renal carcinomas mainly display papillary architecture and belong to a rare histological papillary type II subtype [1, 3 , 5, 16].”
BackgroundInfluentialDownregulation of SRF–FOS–JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas
Raimundo, N., Vanharanta, S., Aaltonen, L. A., Hovatta, I., & Suomalainen, A. (2009) · Oncogene · doi:10.1038/onc.2008.472 · Cited by 33
“FH defects lead to hereditary leiomyomatosis and renal cell cancer, and have been reported in other tumors, such as ovary adenocarcinomas, Leydig cell tumors and cerebral cavernomas (Tomlinson et al., 2002; Alam et al., 2003; Carvajal-Carmona et al., 2006; Ylisaukko-Oja et al., 2006; Campione et al., 2007; Refae et al…”
InfluentialSourbier, C., Romero, V. V., Giubellino, A., Yang, Y., Sudarshan, S., Neckers, L., & Linehan, W. M. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13458 · Cited by 29
“Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant hereditary familial cancer syndrome, characterized by germline mutation of the mitochondrial tricarboxylic acid (TCA) cycle enzyme, fumarate hydratase (FH).(1) Renal tumors associated with HLRCC are very aggressive and tend to metastas…”
BackgroundMolecular and clinical attributes of uterine leiomyomas
Dvorská, D., Braný, D., Daňková, Z., Halášová, E., & Višňovský, J. (2017) · Tumor Biology · doi:10.1177/1010428317710226 · Cited by 31
Pan, X., Zhang, M., Yao, J., Zeng, H., Nie, L., Gong, J., Chen, X., Xu, M., Zhou, Q., & Chen, N. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-205924 · Cited by 29
Gregová, M., Hojny, J., Němejcová, K., Bártů, M., Mára, M., Boudová, B., Laco, J., Krbal, L., Tichá, I., & Dundr, P. (2019) · Pathology & Oncology Research · doi:10.1007/s12253-019-00739-5 · Cited by 29
Alam, N. A., Gorman, P., Jaeger, E. E. M., Kelsell, D. P., Leigh, I. M., Ratnavel, R. C., Murdoch, M. E., Houlston, R. S., Aaltonen, L. A., Roylance, R. R., et al. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00196-1 · Cited by 29
“1 and 2) [12].”
BackgroundTumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review
Webster, B. R., Gopal, N., & Ball, M. W. (2022) · Genes · doi:10.3390/genes13112122 · Cited by 30
No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas
Barker, K. T., Spendlove, H. E., Banu, N. S., Bridge, J. A., Fisher, C., SHIPLEY, J. M., Garrett, M. D., Manyonda, I., & Houlston, R. S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.04.017 · Cited by 28
Metadata
- Authors
- The Multiple Leiomyoma Consortium
- Venue
- Nature Genetics
- Published
- 2002-02-25
- Volume
- 30
- Issue
- 4
- Pages
- 406-410
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1967291345
- Cited by
- 1,635
- References
- 17
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 64 · 2023: 57 · 2022: 65 · 2021: 80 · 2020: 93 · 2019: 86 · 2018: 81 · 2017: 90 · 2016: 106 · 2015: 89 · 2014: 85 · 2013: 82 · 2012: 82
- FWCI
- 56.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- U.S. Public Health Service (U59309)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- fumarate hydratase, FH gene, germline mutations, uterine fibroids, cutaneous leiomyoma, papillary renal cell carcinoma, cancer susceptibility, tumor suppressor, fumarate hydratase deficiency, compound heterozygosity, TCA cycle, fibroid pathogenesis
- MeSH terms
- Alleles, Carcinoma, Papillary, Carcinoma, Renal Cell, Chromosomes, Human, Pair 1, Exons, Female, Fumarate Hydratase, Genes, Dominant, Genetic Markers, Humans, Kidney Neoplasms, Leiomyoma, Male, Mutation, Pedigree, Recombination, Genetic, Uterine Neoplasms, Gene Deletion, In Situ Hybridization, Fluorescence, Sequence Analysis, DNA, Germ-Line Mutation, Leiomyoma, Epithelioid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.